Original Article

Chronic Idiopathic Neutrophilia: Experience and Recommendations

Authors: Alva B. Weir, MD, FACP, James B. Lewis Jr, MD, FACP, Rafael Arteta-Bulos, MD

Abstract

Objectives: To distinguish chronic idiopathic neutrophilia (CIN) in a cost-effective manner from neutrophilia caused by important underlying illnesses.


Methods: This was a retrospective review of patients visiting a Veterans Affairs Medical Center over the last 10 years with a diagnosis of leukocytosis or myeloproliferative disorder. Of this group, fifty-seven patients from 1999 to 2008 were identified with CIN. Clinical and laboratory parameters were examined to identify CIN and establish its course. Eighty-one patients who presented from 2005 to 2010 with myeloproliferative disorders were also studied at time of diagnosis to determine any possible confusion with CIN.


Results: The patients with CIN were followed for a mean of ≥7.3 years without progression to other serious disorders. Compared to non-CIN patients evaluated for neutrophilia, in multiple logistic regression analyses, smoking (P = .001) and increased BMI (P = .004) were significantly associated with CIN. No CIN patient developed a clinically apparent myeloproliferative disorder other than chronic myeloid leukemia (CML). Of the patients with myeloproliferative neoplasms reviewed at the time of their initial diagnosis, only CML occasionally presented with a picture consistent with CIN. For nonsmokers, the BMI of CIN patients was significantly higher than the average VA population (P < .001).


Conclusion: Cigarette smoking and obesity are confirmed as factors associated with CIN and may be causative. CIN is unlikely to develop into a clinically recognizable myeloproliferative neoplasm other than CML. Cost-effective guidelines for the diagnostic evaluation of neutrophilia in otherwise healthy patients are presented.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Ward HN, Reinhard EH. Chronic idiopathic leukocytosis. Ann Intern Med 1971;75:193-198.
 
2. Stemmelin GR, Doti CA, Shanley CM, et al. Smoking as a cause for mild chronic neutrophilia. Blood 2004;104. Abstract 3796.
 
3. Parry H, Cohen S, Schlarb JE, et al. Smoking, alcohol consumption and leukocyte counts. Am J Clin Pathol 1997;107:64-67.
 
4. Corre F, Lellouch J, Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet 1971;2:632-634.
 
5. Noble RC, Penny BB. Comparison of leukocyte count and function in smoking and nonsmoking young men. Infect Immun 1975;12:550-555.
 
6. Smith MR, Kinmonth A, Luben RN, et al. Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis 2003;169:331-337.
 
7. Herishanu Y, Rogowski O, Polliack A, et al. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 2006;76:516-520.
 
8. Suzuki K, Kitagawa S. Chronic idiopathic leukocytosis. Ryoikibetsu Shokogun Shirizu 1998;21(Pt 2):17-18.
 
9. Schwartz J, Weiss S. Host and environmental factors influencing the peripheral blood leukocyte count. Am J Epidemiol 1991;134:1402-1409.
 
10. Koury MJ, Mahmud N, Rhodes MM. Origin and development of blood cells. In: Greer JP, Foerster J, Rodgers GM, et al (eds): Wintrobe's Clinical Hematology. 12th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2009:95.
 
11. Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med 2006;355:2452-2466.
 
12. Spivak JL, Silver RT. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood 2008;112:231-239.
 
13. Quintás-Cardama A, Cortes JE. Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc 2006;81:973-988.
 
14. Tefferi A, Barbui T. Bcr/abl-negative, classic myeloproliferative disorders: diagnosis and treatment. Mayo Clin Proc 2005;80:1220-1232.
 
15. Komrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am 2010;24:443-457.
 
16. Van Eeden SF, Hogg JC. The response of human bone marrow to chronic cigarette smoking. Eur Respir J 2000;15:915-921.
 
17. Francus T, Romano PM, Manzo G, et al. IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol 1992;145:156-174.
 
18. Wannamethee SG, Lowe GDO, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-1773.
 
19. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007;131:1557-1566.
 
20. Laharrague P, Oppert JM, Brousset P, et al. High concentration of leptin stimulates myeloid differentiation from human bone marrow CD34+ progenitors: potential involvement in leukocytosis of obese subjects. Int J Obesity 2000;24:1212-1216.
 
21. Reichard KK, Larson RS, Rabinowitz I. Chronic myeloid leukemia. In: Greer JP, Foerster J, Rodgers GM, et al (eds): Wintrobe's Clinical Hematology. 12th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2009:2009.
 
22. Athens JW, Raab SO, Haab OP, et al. Leukokinetic studies. III. The distribution of granulocytes in the blood of normal subjects. J Clin Invest 1961;40:159-164.
 
23. Bremner JD, Krystal JH, Southwick SM, et al. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 1996;23:39-51.
 
24. Arranz L, Guayerbas N, De la Fuente M. Impairment of several immune functions in anxious women. J Psychosom Res 2007;62:1-8.
 
25. Grann V, Ziv E, Joseph C, et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe, and the Caribbean. Br J Haematol 2008;143:288-293.